Dr Gabby Goldberg is Operations Manager of Synthesis Research and its investee companies Anaxis Pharma and Catalyst Therapeutics – joint ventures with the Walter and Eliza Hall Institute of Medical Research. She has over 15 years’ experience leading translational research. Her PhD with Prof. Richard Boyd at Monash University resulted in several high-impact publications and a multi-centre clinical trial. She went on to do post-doctoral fellowships in translational immunology at Memorial Sloan-Kettering Cancer Center and Baylor Institute of Immunology Research. Upon her return to Australia, she accepted a Senior Research Officer position with Prof. Ian Wicks at the Walter and Eliza Hall Institute. Working on a CSL Ltd. funded project, she undertook and coordinated a preclinical drug development program involving clinical, academic and industry staff. A year after joining the lab, she was awarded an NHMRC Career Development Fellowship (Industry) which afforded her the opportunity to work on secondment at CSL and play an integral role in the research leading up to the IND filing of a novel drug targeting inflammatory diseases.